Latest Blog Posts Tagged "Clinical Scales"
August 07, 2014
MJFF is working with the FDA to define parameters for clinical trials of drugs to treat mild cognitive impairment with Parkinson's disease or PD-MCI.
June 05, 2014
Our monthly roundup of projects that we've recently funded includes ones that span our research portfolio. These grants support work on motor symptoms, cognition and genetics.
December 14, 2012
On Thursday, December 13, the Foundation hosted the final event of the year in its Hot Topics in Parkinson's disease Research Seminar Series: "PD Research 2012: How Far We've Come and What Lies Ahead"
The Parkinson's Minute: Unified Dyskinesia Rating Scale Provides Common Yardstick for Drug Developers
June 01, 2012
In this MJFF's video series, Dave Iverson reports that researchers have identified the best clinical scale for measuring patient response to therapies to treat dyskinesia.
Weighing Different Scales: Unified Dyskinesia Rating Scale Comes out on Top, Could Speed Development of New Dyskinesia Treatments
May 01, 2012
Researchers have identified the best clinical scale for measuring patient response to therapies to treat dyskinesia, the debilitating, uncontrollable movements that are often a side effect of PD drugs